Alcon Inc. - Registered Shares

Alcon Inc. - Registered Shares

ALC

Market Cap$42.51B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alcon Inc. - Registered SharesAlcon Inc. - Registered Shares380.39%5%4.30.2

Earnings Call Q1 2025

May 14, 2025 - AI Summary

Sales Performance and Growth Forecast: Alcon reported first quarter sales of $2.5 billion, reflecting a 3% growth year-over-year. However, the company has tempered its full-year sales growth guidance to between 6% and 7% in constant currency, down from previous estimates, largely due to softness in the U.S. surgical market.
Product Launches and Innovations: The company is optimistic about several upcoming product launches, primarily Unity VCS and PanOptix Pro, which are expected to drive significant sales growth in the second half of 2025. They anticipate a revenue acceleration, particularly with new product rollouts and expect high-single-digit growth in the back half of the year.
Challenges in the U.S. Surgical Market: Alcon continues to face challenges within the U.S. surgical market, primarily attributed to an ongoing slowdown in procedures and competition from other companies, which has led to a downgrade in their growth expectations for the cataract market.

Exclusive for Stockcircle Pro members

Sign upSign Up
$28.40

Current Fair Value

66.8% downside

Overvalued by 66.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$42.51 Billion
Enterprise Value$46.41 Billion
Dividend Yield$0.3334 (0.387945077961368%)
Earnings per Share$2.06
Beta0.75
Outstanding Shares495,100,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio37.99
PEG92.37
Price to Sales4.27
Price to Book Ratio1.94
Enterprise Value to Revenue4.67
Enterprise Value to EBIT30.58
Enterprise Value to Net Income41
Total Debt to Enterprise0.11
Debt to Equity0.24

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Alcon, Inc.

20,000 employees
CEO: David J. Endicott

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the followi...